• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

TRIBUTYRIN Drug Record

  • Summary
  • Interactions
  • Claims
  • TRIBUTYRIN chembl:CHEMBL118722

    Alternate Names:

    FEMA NO. 2223
    TRIBUTYRIN
    NSC-661583

    Drug Info:

    (0 More Sources)

    Publications:

    Munshi et al., 2005, Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity., Clin. Cancer Res.
    Su et al., 2006, Evaluation of tributyrin lipid emulsion with affinity to low-density lipoprotein: pharmacokinetics in adult male Wistar rats and cellular activity on Caco-2 and HepG2 cell lines., J. Pharmacol. Exp. Ther.
    Chen et al., 1999, Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells., Chin. Med. J.
    Kushak et al., 1999, Regulation of intestinal peptidases by nutrients in human fetuses and children., Comp. Biochem. Physiol., Part A Mol. Integr. Physiol.
  • TRIBUTYRIN   XRCC5

    Interaction Score: 6.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16000590


    Sources:
    NCI

  • TRIBUTYRIN   ANPEP

    Interaction Score: 2.81

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    10629959


    Sources:
    NCI

  • TRIBUTYRIN   LDLR

    Interaction Score: 1.47

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    16188956


    Sources:
    NCI

  • TRIBUTYRIN   RARA

    Interaction Score: 1.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11593538


    Sources:
    NCI

  • NCI: TRIBUTYRIN

    • Version: 14-September-2017

    Alternate Names:
    C1260 NCI drug code

    Drug Info:

    Publications:
    Chen et al., 1999, Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells., Chin. Med. J.
    Munshi et al., 2005, Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity., Clin. Cancer Res.
    Su et al., 2006, Evaluation of tributyrin lipid emulsion with affinity to low-density lipoprotein: pharmacokinetics in adult male Wistar rats and cellular activity on Caco-2 and HepG2 cell lines., J. Pharmacol. Exp. Ther.

  • ChemblDrugs: chembl:CHEMBL118722

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21